Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 324

1.

PEG-chitosan-coated iron oxide nanoparticles with high saturated magnetization as carriers of 10-hydroxycamptothecin: preparation, characterization and cytotoxicity studies.

Qu JB, Shao HH, Jing GL, Huang F.

Colloids Surf B Biointerfaces. 2013 Feb 1;102:37-44. doi: 10.1016/j.colsurfb.2012.08.004. Epub 2012 Aug 19.

PMID:
23000675
2.

Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.

Hong M, Zhu S, Jiang Y, Tang G, Sun C, Fang C, Shi B, Pei Y.

J Control Release. 2010 Jan 4;141(1):22-9. doi: 10.1016/j.jconrel.2009.08.024. Epub 2009 Sep 4.

PMID:
19735683
3.

Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery.

Zu Y, Meng L, Zhao X, Ge Y, Yu X, Zhang Y, Deng Y.

Int J Nanomedicine. 2013;8:1207-22. doi: 10.2147/IJN.S40493. Epub 2013 Mar 27.

4.

Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect.

Wang A, Li S.

BMC Biotechnol. 2008 May 4;8:46. doi: 10.1186/1472-6750-8-46.

5.

Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying.

Zhang X, Pan W, Gan L, Zhu C, Gan Y, Nie S.

Chem Pharm Bull (Tokyo). 2008 Dec;56(12):1645-50.

6.

Polysaccharide surface modified Fe3O4 nanoparticles for camptothecin loading and release.

Zhu A, Yuan L, Jin W, Dai S, Wang Q, Xue Z, Qin A.

Acta Biomater. 2009 Jun;5(5):1489-98. doi: 10.1016/j.actbio.2008.10.022. Epub 2008 Nov 14.

PMID:
19286431
7.

Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.

Yang L, Cui F, Cun D, Tao A, Shi K, Lin W.

Int J Pharm. 2007 Aug 1;340(1-2):163-72. Epub 2007 Mar 25.

PMID:
17482779
8.

[Preparation of PEG-modified nanostructured lipid carriers loaded with hydroxycamptothecin and tissue distribution in mice].

Zhang XX, Gan Y, Yang XG, Zhu CL, Gan L, Nie SF, Pan WS.

Yao Xue Xue Bao. 2008 Jan;43(1):91-6. Chinese.

PMID:
18357740
9.

Preparation and properties of hydroxycamptothecin-loaded nanoparticles made of amphiphilic copolymer and normal polymer.

Wang J, Wang R, Li LB.

J Colloid Interface Sci. 2009 Aug 15;336(2):808-13. doi: 10.1016/j.jcis.2009.04.080. Epub 2009 May 12.

PMID:
19520376
10.

Actively-targeted LTVSPWY peptide-modified magnetic nanoparticles for tumor imaging.

Jie LY, Cai LL, Wang LJ, Ying XY, Yu RS, Zhang MM, Du YZ.

Int J Nanomedicine. 2012;7:3981-9. doi: 10.2147/IJN.S33593. Epub 2012 Jul 24.

11.
12.

Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.

Parveen S, Sahoo SK.

Eur J Pharmacol. 2011 Nov 30;670(2-3):372-83. doi: 10.1016/j.ejphar.2011.09.023. Epub 2011 Sep 21. Erratum in: Eur J Pharmacol. 2014 Mar 15;727:186.

PMID:
21951969
13.

Chitosan-coated magnetic nanoparticles as carriers of 5-fluorouracil: preparation, characterization and cytotoxicity studies.

Zhu L, Ma J, Jia N, Zhao Y, Shen H.

Colloids Surf B Biointerfaces. 2009 Jan 1;68(1):1-6. doi: 10.1016/j.colsurfb.2008.07.020. Epub 2008 Aug 15.

PMID:
19013060
14.

Polyelectrolyte nanoparticles based on water-soluble chitosan-poly(L-aspartic acid)-polyethylene glycol for controlled protein release.

Shu S, Zhang X, Teng D, Wang Z, Li C.

Carbohydr Res. 2009 Jul 6;344(10):1197-204. doi: 10.1016/j.carres.2009.04.018. Epub 2009 Apr 20.

PMID:
19508912
15.

Preparation of carboplatin-Fe@C-loaded chitosan nanoparticles and study on hyperthermia combined with pharmacotherapy for liver cancer.

Li FR, Yan WH, Guo YH, Qi H, Zhou HX.

Int J Hyperthermia. 2009 Aug;25(5):383-91. doi: 10.1080/02656730902834949.

PMID:
19391033
16.

PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer.

Zhang X, Gan Y, Gan L, Nie S, Pan W.

J Pharm Pharmacol. 2008 Aug;60(8):1077-87. doi: 10.1211/jpp.60.8.0014.

PMID:
18644200
17.
18.

Chitosan surface-modified hydroxycamptothecin loaded nanoparticles with enhanced transport across Caco-2 cell monolayer.

Zhang L, Sun M, Guo R, Jiang Z, Liu Y, Jiang X, Yang C.

J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):2912-20.

PMID:
17048498
19.

Development of chitosan-based nanoparticles through inter-polymeric complexation for oral drug delivery.

Jana S, Maji N, Nayak AK, Sen KK, Basu SK.

Carbohydr Polym. 2013 Oct 15;98(1):870-6. doi: 10.1016/j.carbpol.2013.06.064. Epub 2013 Jul 5.

PMID:
23987423
20.

Novel magnetic iron oxide nanoparticles coated with poly(ethylene imine)-g-poly(ethylene glycol) for potential biomedical application: synthesis, stability, cytotoxicity and MR imaging.

Schweiger C, Pietzonka C, Heverhagen J, Kissel T.

Int J Pharm. 2011 Apr 15;408(1-2):130-7. doi: 10.1016/j.ijpharm.2010.12.046. Epub 2011 Feb 18.

PMID:
21315813
Items per page

Supplemental Content

Write to the Help Desk